Literature DB >> 7821762

Single-chain Fvs.

R Raag1, M Whitlow.   

Abstract

Single-chain Fvs (sFvs) are recombinant antibody fragments consisting of only the variable light chain (VL) and variable heavy chain (VH) domains covalently connected to one another by a polypeptide linker. Due to their small size, sFvs have rapid pharmacokinetics and tumor penetration in vivo. Single-chain Fvs also show a concentration-dependent tendency to oligomerize. Bivalent sFvs are formed when the variable domains of a sFv disassociate from one another and reassociate with the variable domains of a second sFv. Similar rearrangement and reassociation of variable domains from different sFvs can result in the formation of trimers or higher multimeric oligomers. Each Fv in a bivalent or multivalent Fv is composed of the VL domain from one sFv and the VH domain from a second sFv. Modifying linker length or the inclusion of antigen may stabilize the VL/VH interface against rearrangement such that specific multimeric or monomeric forms of sFvs may be isolated. Nuclear magnetic resonance studies have shown that McPC603-derived Fv and sFvs have similar structures, and that the sFv linker is a rapidly moving, highly flexible peptide with a random coil-like structure. In X-ray crystallographic investigations of three different sFvs, linkers have also been found to be disordered. Indirect evidence suggests that a monomeric sFv has been crystallized in one case, and dimeric sFvs in the other two.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7821762     DOI: 10.1096/fasebj.9.1.7821762

Source DB:  PubMed          Journal:  FASEB J        ISSN: 0892-6638            Impact factor:   5.191


  33 in total

1.  Design of three-dimensional domain-swapped dimers and fibrous oligomers.

Authors:  N L Ogihara; G Ghirlanda; J W Bryson; M Gingery; W F DeGrado; D Eisenberg
Journal:  Proc Natl Acad Sci U S A       Date:  2001-02-13       Impact factor: 11.205

2.  Conversion of monomeric protein L to an obligate dimer by computational protein design.

Authors:  B Kuhlman; J W O'Neill; D E Kim; K Y Zhang; D Baker
Journal:  Proc Natl Acad Sci U S A       Date:  2001-08-28       Impact factor: 11.205

3.  Three-dimensional domain swapping in p13suc1 occurs in the unfolded state and is controlled by conserved proline residues.

Authors:  F Rousseau; J W Schymkowitz; H R Wilkinson; L S Itzhaki
Journal:  Proc Natl Acad Sci U S A       Date:  2001-05-08       Impact factor: 11.205

4.  Making artificial antibodies: a format for phage display of combinatorial heterodimeric arrays.

Authors:  C Gao; S Mao; C H Lo; P Wirsching; R A Lerner; K D Janda
Journal:  Proc Natl Acad Sci U S A       Date:  1999-05-25       Impact factor: 11.205

5.  A method for the generation of combinatorial antibody libraries using pIX phage display.

Authors:  Changshou Gao; Shenlan Mao; Gunnar Kaufmann; Peter Wirsching; Richard A Lerner; Kim D Janda
Journal:  Proc Natl Acad Sci U S A       Date:  2002-09-18       Impact factor: 11.205

6.  Paracrine inhibition of prion propagation by anti-PrP single-chain Fv miniantibodies.

Authors:  Gaetano Donofrio; Frank L Heppner; Magdalini Polymenidou; Christine Musahl; Adriano Aguzzi
Journal:  J Virol       Date:  2005-07       Impact factor: 5.103

7.  Engineering anti-vascular endothelial growth factor single chain disulfide-stabilized antibody variable fragments (sc-dsFv) with phage-displayed sc-dsFv libraries.

Authors:  Yi-Jen Huang; Ing-Chien Chen; Chung-Ming Yu; Yu-Ching Lee; Hung-Ju Hsu; Anna Tung Ching Ching; Hung-Ju Chang; An-Suei Yang
Journal:  J Biol Chem       Date:  2010-01-12       Impact factor: 5.157

8.  Engineering subunit association of multisubunit proteins: a dimeric streptavidin.

Authors:  T Sano; S Vajda; C L Smith; C R Cantor
Journal:  Proc Natl Acad Sci U S A       Date:  1997-06-10       Impact factor: 11.205

Review 9.  Tyrosine kinase inhibitors targeted to the epidermal growth factor receptor subfamily: role as anticancer agents.

Authors:  S B Noonberg; C C Benz
Journal:  Drugs       Date:  2000-04       Impact factor: 9.546

10.  CODV-Ig, a universal bispecific tetravalent and multifunctional immunoglobulin format for medical applications.

Authors:  Anke Steinmetz; François Vallée; Christian Beil; Christian Lange; Nicolas Baurin; Jochen Beninga; Cécile Capdevila; Carsten Corvey; Alain Dupuy; Paul Ferrari; Alexey Rak; Peter Wonerow; Jochen Kruip; Vincent Mikol; Ercole Rao
Journal:  MAbs       Date:  2016-03-16       Impact factor: 5.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.